Growth impairment in CKD can be attributed to nutritional deficiencies, metabolic acidosis, secondary hyperparathyroidism (SHPT), imbalances in the growth hormone/insulin-like growth factor 1 axis, pubertal dysfunction, appetite disorders, and the toxicity of certain medications such as corticosteroids [35]. The gene discussed is GH1; the disease is secondary hyperparathyroidism.